4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001209191-21-070810
Options or other derivatives
- Chief Scientific Officer acquired 147,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kanner Steven · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-20 | Grant or award : show line 1 in the form Option to purchase Common Stock | +147,000 | 147,000 | D |
Loading xslF345X03/doc4.xml…